Department of Diagnostic, Molecular and Interventional Radiology

Our department is committed to focusing on early detection and diagnosis; treatment and prevention; and research. As a student in our department’s residencies and fellowships, you benefit from our expertise in state-of-the-art equipment. We use filmless digital technology that spans:

  • Interventional radiology
  • Magnetic resonance imaging (MRI)
  • Multi-slice computed tomography (CT)
  • Positron emission tomography (PET)
  • Single-photon emission computed tomography
  • Advanced ultrasound
  • Conventional radiography
  • Digital mammography
  • Picture archiving communication system technology

You also get the opportunity to collaborate closely with surgeons, oncologists, and other caregivers to optimize the diagnosis and treatment of patients with head and neck, liver, lung, breast, and gastrointestinal cancers.

As an additional bonus, The Mount Sinai Hospital serves as the official hospital of the U.S. Tennis Association. As such, we provide imaging services for the U.S. Open Tennis Championships, including the performance of diagnostic and therapeutic ultrasounds onsite at the tournament.

Early Detection and Diagnosis

We use a variety of imaging techniques for early detection and comprehensive diagnosis. As a student in our department, you gain experience in using CT and MRI for atherosclerosis; CT and MR angiography for vascular diseases; CT for colon cancer; PET for oncology; and digital mammography, MRI, ultrasound, and computer-aided diagnosis for breast cancer. We also provide radiological screenings for atherosclerosis as well as colon, breast, and lung cancers.

Treatment and Prevention

We use radiology to provide sophisticated therapeutic interventions, notably:

  • Biopsies
  • Vascular therapies
  • Uterine artery embolization for fibroids (an alternative to hysterectomy)
  • Treatments for aneurysms, atherosclerosis, and many types of cancer


Our scientists and physicians are actively involved in imaging research and development. We have developed a special form of MRI to diagnose heart disease and atherosclerosis noninvasively, thereby identifying patients at greatest risk for heart attack and stroke. This technique, the black-blood MRI, causes blood to appear dark while vessel walls appear bright. This method allows our cardiologists to identify thickening of the artery wall, an indication of otherwise undetectable plaques.

We collaborate with other disciplines to develop and refine imaging tools to improve prevention and diagnosis. We work with:

  • Neuroscience, to improve our understanding of neurodegenerative conditions such as Parkinson’s disease, multiple sclerosis, stroke, brain tumors, and various psychiatric disorders
  • Cardiology, to predict the risk associated with atherosclerotic plaques and assess new therapies for aortic and cerebral artery aneurysms
  • Hepatology, to develop optimal therapeutic strategies for liver diseases